zoledronic acid has been researched along with Soft Tissue Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bitsch, F; Cotesta, S; Geiser, M; Glickman, JF; Götte, M; Green, JR; Hemmig, R; Henry, C; Jahnke, W; Lehmann, S; Marzinzik, A; Pellé, X; Roddy, TP; Rondeau, JM; Stout, SJ; Strauss, A | 1 |
| Brountzos, E; Gouliamos, A; Kouloulias, V; Mystakidou, K; Panagiotou, I | 1 |
2 other study(ies) available for zoledronic acid and Soft Tissue Neoplasms
| Article | Year |
|---|---|
Allosteric non-bisphosphonate FPPS inhibitors identified by fragment-based discovery.
Topics: Allosteric Regulation; Allosteric Site; Bone and Bones; Crystallography, X-Ray; Diphosphonates; Drug Evaluation, Preclinical; Enzyme Inhibitors; Geranyltranstransferase; Humans; Imidazoles; Magnetic Resonance Spectroscopy; Soft Tissue Neoplasms; Zoledronic Acid | 2010 |
Well-differentiated hand liposarcoma with bone metastases treated successfully with zoledronic Acid.
Topics: Bone Density Conservation Agents; Bone Neoplasms; Diphosphonates; Hand; Humans; Imidazoles; Liposarcoma; Male; Middle Aged; Soft Tissue Neoplasms; Treatment Outcome; Zoledronic Acid | 2011 |